logo-loader

XPhyto German partner 3a Diagnostics planning to develop two saliva tests for Coronavirus

Published: 15:35 28 Oct 2020 EDT

XPhyto (CSE: XPHY-OTC: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive to bring news their exclusive diagnostic partner, 3a-Diagnostics is developing a reverse transcription-polymerase chain reaction kit targeting COVID-19 with results in 25 minutes.

Rogers telling Proactive they are planning two test kits and they expect to launch them in the European market in Q-1 2021.

ARway.ai announces multiple new SaaS developer contracts in both the United...

ARway.ai (CSE:ARWY, OTCQB:ARWYF) Chief Executive Officer Evan Gappelberg joined Steve Darling from Proactive to announce multiple new SaaS developer sign-ups for its augmented reality experience platform, focusing on AR indoor navigation. These partnerships represent significant milestones in...

1 hour, 36 minutes ago